KLDO — Kaleido Biosciences Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$16.78m
- $1.10m
Brief: Kaleido Biosciences Reports Q1 Loss Per Share $0.64
Brief: Kaleido Biosciences Initiates Controlled Clinical Study Of Microbiome Metabolic Therapy Kb109 In Outpatients With Mild-To-Moderate COVID-19
Brief: Kaleido Biosciences Appoints Anne Prener To Its Board Of Directors
U.S. RESEARCH ROUNDUP -Alphabet, Facebook, Motorola Solutions
Brief: Kaleido Biosciences Inc Files For Mixed Shelf Of Up To $100 Million
Brief: Kaleido Biosciences Reports Q4 Loss Per Share $0.65
Brief: Kaleido Biosciences Announces Collaboration With Janssen
Brief: Kaleido Biosciences And Cadena Bio Enters Into Credit Agreement With Hercules Capital
Kaleido Biosciences jumps on positive data from liver disease trial
Brief: Kaleido Biosciences Inc - Kb174 Exceeded Targeted Reduction In A Biomarker Of Microbiome Ammonia Production
Brief: Kaleido Biosciences Appoints William Duke As Chief Financial Officer
Kaleido Biosciences drops on workforce, manufacturing cuts to conserve cash
Brief: Kaleido Biosciences Says Co & Cadena Bio Entered Into Credit Agreement With JPMorgan Chase Bank
Brief: Kaleido Biosciences Reports Third Quarter 2019 Financial Results And Provides Corporate Update
Brief: Kaleido Biosciences Announces CFO Transition
Brief: Kaleido Biosciences To Collaborate With Gustave Roussy Cancer Center
U.S. STOCKS ON THE MOVE-General Electric, Barrick Gold, CannTrust Holdings
NASDAQ RESUMED
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE